<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 5; Issue 3</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(May-Jun, 2024)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>2024</Year>
        <Month>05</Month>
        <Day>20</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>A Unique Case of Neuromyelitis Optica in a Patient with Acquired Immunodeficiency Syndrome: Case Report</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>7</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Hailey</FirstName>
          <LastName>Mair</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Joshua</FirstName>
          <LastName>Chalkley</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Roman</FirstName>
          <LastName>Kassa</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Flavius D.</FirstName>
          <LastName>Raslau</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Ashwini</FirstName>
          <LastName>Kini</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Padmaja</FirstName>
          <LastName>Sudhakar</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Introduction: Neuromyelitis optica (NMO) is an inflammatory, demyelinating central nervous system disorder characterized by concurrence of optic neuritis associated with a lesion in the spinal cord extending over three or more vertebral segments.&#13;
&#13;
Clinical Case: We describe a patient with acquired immunodeficiency syndrome (AIDS) who presented with acute myelopathy and optic neuritis and subsequently was diagnosed with NMO. Conclusions: This case highlights the importance of including NMO in the differential diagnosis when an AIDS patient presents with optic neuritis or myelitis. Timely diagnosis of NMO is essential for adequate treatment and recovery.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Neuromyelitis Optica (NMO),AIDS,Demyelinating Disease,Optic Neuritis</Keywords>
      <URLs>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=15192&amp;title=A Unique Case of Neuromyelitis Optica in a Patient with Acquired Immunodeficiency Syndrome: Case Report</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Norenberg M. Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology 1989; 39: 324-329.&#13;
&#13;
Berger JR, Tornatore C, Major EO, Bruce J, Shapshak P, Yoshioka M, Houff S, Sheremata W, Horton GF, Landy H. Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy. Ann Neurol 1992; 31: 34-38.&#13;
&#13;
Blanche P, Diaz E, Gombert B, Sicard D, Rivoal O, Brezin A. Devicand;#39;s neuromyelitis optica and HIV-1 infection. J Neurol Neurosurg Psychiatry 2000; 68: 795-796.&#13;
&#13;
Feyissa AM, Singh P, Smith RG. Neuromyelitis optica in patients with coexisting human immunodeficiency virus infections. Mult Scler 2013; 19: 1363-1366.&#13;
&#13;
Higuchi M, Nagasawa K, Horiuchi T, Oike M, Ito Y, Yasukawa M, Niho Y. Membrane tumor necrosis factor-alpha (TNF-alpha) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation--characterization of membrane TNF-alpha. Clin Immunol Immunopathol 1997; 82: 133-140.&#13;
&#13;
Kessler RA, Mealy MA, Levy M. Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic. Curr Treat Options Neurol 2016; 18: 2.&#13;
&#13;
Koga M, Takahashi T, Kawai M, Fujihara K, Kanda T. A serological analysis of viral and bacterial infections associated with neuromyelitis optica. J Neurol Sci 2011; 300: 19-22.&#13;
&#13;
Mathew T, Avati A, Dand;#39;Souza D, Therambil M, Baptist AA, Shaji A, Nadig R, Rockey SM, Parry G. HIV infection associated neuromyelitis optica spectrum disorder: Clinical features, imaging findings, management and outcomes. Mult Scler Relat Disord 2019; 27: 289-293.&#13;
&#13;
Schmetzer O, Lakin E, Roediger B, Duchow A, Asseyer S, Paul F, Siebert N. Anti-aquaporin 4 IgG Is Not Associated with Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder. Front Neurol 2021; 12: 635419.&#13;
&#13;
Sellner J, Hemmer B, Mand;uuml;hlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun 2010; 34: 371-379.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>